These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9011004)

  • 1. The role of glycoproteins gC, gE, gI, and gG in the induction of cell-mediated immune responses to bovine herpesvirus 1.
    Denis M; Hanon E; Rijsewijk FA; Kaashoek MJ; van Oirschot JT; Thiry E; Pastoret PP
    Vet Microbiol; 1996 Nov; 53(1-2):121-32. PubMed ID: 9011004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene.
    Kaashoek MJ; Rijsewijk FA; Ruuls RC; Keil GM; Thiry E; Pastoret PP; Van Oirschot JT
    Vaccine; 1998 May; 16(8):802-9. PubMed ID: 9627937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments.
    Mars MH; de Jong MC; van Oirschot JT
    Vaccine; 2000 Apr; 18(19):1975-81. PubMed ID: 10706958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of cattle with a BHV1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV.
    Schrijver RS; Langedijk JP; Keil GM; Middel WG; Maris-Veldhuis M; Van Oirschot JT; Rijsewijk FA
    Vaccine; 1997 Dec; 15(17-18):1908-16. PubMed ID: 9413101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitopes on glycoprotein E and on the glycoprotein E/glycoprotein I complex of bovine herpesvirus 1 are expressed by all of 222 isolates and 11 vaccine strains.
    Rijsewijk FA; Kaashoek MJ; Langeveld JP; Maris-Veldhuis MA; Magdalena J; Verschuren SB; Meloen RH; van Oirschot JT
    Arch Virol; 2000; 145(5):921-36. PubMed ID: 10881679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs.
    Strube W; Auer S; Block W; Heinen E; Kretzdorn D; Rodenbach C; Schmeer N
    Vet Microbiol; 1996 Nov; 53(1-2):181-9. PubMed ID: 9011010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivation of latent bovine herpesvirus 1 in cattle seronegative to glycoproteins gB and gE.
    Hage JJ; Glas RD; Westra HH; Maris-Veldhuis MA; Van Oirschot JT; Rijsewijk FA
    Vet Microbiol; 1998 Feb; 60(2-4):87-98. PubMed ID: 9646441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early immunity induced by a live gE-negative bovine herpesvirus 1 marker vaccine.
    Kaashoek MJ; van Oirschot JT
    Vet Microbiol; 1996 Nov; 53(1-2):191-7. PubMed ID: 9011011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine herpesvirus type 1 (BHV-1) mutant lacking U(L)49.5 luminal domain residues 30-32 and cytoplasmic tail residues 80-96 induces more rapid onset of virus neutralizing antibody and cellular immune responses in calves than the wild-type strain Cooper.
    Wei H; He J; Paulsen DB; Chowdhury SI
    Vet Immunol Immunopathol; 2012 Jun; 147(3-4):223-9. PubMed ID: 22578851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies.
    Lemaire M; Schynts F; Meyer G; Georgin JP; Baranowski E; Gabriel A; Ros C; Belák S; Thiry E
    Vaccine; 2001 Sep; 19(32):4795-804. PubMed ID: 11535332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
    Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
    Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation by self re-fusion of bovine³ × murine² heterohybridomas secreting virus-neutralizing bovine monoclonal antibodies to bovine herpesvirus 1 glycoproteins gB, gC, and gD.
    Levings RL; Stoll IR; Warg JV; Patterson PA; Hobbs LA; Kaeberle ML; Roth JA
    Vet Immunol Immunopathol; 2014 May; 159(1-2):58-73. PubMed ID: 24629764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a live glycoprotein E-negative bovine herpesvirus 1 vaccine in cattle in the field.
    Mars MH; de Jong MC; Franken P; van Oirschot JT
    Vaccine; 2001 Feb; 19(15-16):1924-30. PubMed ID: 11228362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of latency associated with glycoprotein E (gE) seroconversion after bovine herpesvirus 1 infection in calves with high levels of passive antibodies lacking gE antibodies.
    Schynts F; Lemaire M; Ros C; Belak S; Thiry E
    Vet Microbiol; 2001 Sep; 82(3):211-22. PubMed ID: 11470543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations.
    Mars MH; de Jong MC; van Oirschot JT
    Vaccine; 2000 Apr; 18(20):2120-4. PubMed ID: 10715526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the development and evaluation of bovine herpesvirus 1 vaccines.
    van Oirschot JT; Kaashoek MJ; Rijsewijk FA
    Vet Microbiol; 1996 Nov; 53(1-2):43-54. PubMed ID: 9010997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strains of bovine herpesvirus 1 that do not express an epitope on glycoprotein E in cell culture still induce antibodies that can be detected in a gE-blocking ELISA.
    van Oirschot JT; Kaashoek MJ; Maris-Veldhuis MA; Rijsewijk FA
    Vet Microbiol; 1999 Mar; 65(2):103-13. PubMed ID: 10078594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a gE-negative bovine herpesvirus type 1 vaccine confers insufficient protection to a bovine herpesvirus type 5 challenge.
    Silva AD; Spilki FR; Franco AC; Esteves PA; Hübner SO; Driemeier D; Oliveira AP; Rijsewijk F; Roehe PM
    Vaccine; 2006 Apr; 24(16):3313-20. PubMed ID: 16480790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence and immunogenicity in calves of thymidine kinase- and glycoprotein E-negative bovine herpesvirus 1 mutants.
    Kaashoek MJ; van Engelenburg FA; Moerman A; Gielkens AL; Rijsewijk FA; van Oirschot JT
    Vet Microbiol; 1996 Jan; 48(1-2):143-53. PubMed ID: 8701570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.